Increasing the efficacy of treatment of staphylococcus aureus-candida albicans mixed infections with myrtenol

HIGHLIGHTS

  • who: Ruba Y. Mahmoud and colleagues from the Institute of Fundamental Medicine and Biology, Kazan Federal University, Kazan, Russia have published the article: Increasing the Efficacy of Treatment of Staphylococcus aureus-Candida albicans Mixed Infections with Myrtenol, in the Journal: Antibiotics 2022, 1743 of /2022/
  • what: The authors show that myrtenol potentiates the antimicrobial and biofilm-preventing activity of conventional drugs against aureus and C. mono- and dual-species cultures.

SUMMARY

    Infectious diseases caused by various nosocomial bacteria and fungi like Enterobacteriaceae (Klebsiella sp. and Escherichia coli), Staphylococcus aureus, Candida albicans . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?